Weaning from inhaled corticosteroids in COPD: the evidence
Authors:
- 31 October 2015
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 46 (5) , 1232-1235
Abstract
Much inappropriate use of inhaled corticosteroids in COPD can be safely replaced with long-acting bronchodilators http://ow.ly/QvMRdKeywords
This publication has 13 references indexed in Scilit:
- Inhaled corticosteroids in COPD: the clinical evidenceEuropean Respiratory Journal, 2014
- INSTEAD: a randomised switch trial of indacaterolversussalmeterol/fluticasone in moderate COPDEuropean Respiratory Journal, 2014
- Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPDNew England Journal of Medicine, 2014
- Real-life use of fluticasone propionate/salmeterol in patients with chronic obstructive pulmonary disease: a French observational studyBMC Pulmonary Medicine, 2014
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2013
- How far is real life from COPD therapy guidelines? An Italian observational studyRespiratory Medicine, 2012
- Inhaled corticosteroids in COPD: a case in favourEuropean Respiratory Journal, 2009
- Inhaled corticosteroids in COPD: the case against: Fig. 1—European Respiratory Journal, 2009
- Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trialThorax, 2005
- Effect of Discontinuation of Inhaled Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease: The COPE StudyAmerican Journal of Respiratory and Critical Care Medicine, 2002